Hiroto Katoh Selected Research

Hiroto Katoh Research Topics

Disease

26	Neoplasms (Cancer) 02/2024 - 11/2006
6	Stomach Neoplasms (Stomach Cancer) 10/2022 - 01/2017
4	Neoplasm Metastasis (Metastasis) 02/2023 - 02/2017
3	Carcinogenesis 01/2022 - 02/2017
2	Inflammation (Inflammations) 12/2023 - 11/2023
2	Interstitial Cystitis (Interstitial Cystitis, Chronic) 11/2023 - 01/2019
2	Autoimmune Diseases (Autoimmune Disease) 10/2020 - 03/2013
2	Squamous Cell Carcinoma of Head and Neck 01/2019 - 02/2017
2	Prostatic Neoplasms (Prostate Cancer) 03/2011 - 11/2010
1	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2023
1	Hyperplasia 12/2023
1	Bites and Stings (Sting) 11/2023
1	Cystitis 11/2023
1	Pelvic Pain 11/2023
1	Cholangiocarcinoma 10/2022
1	Meningioma (Meningiomas) 01/2022
1	Chromosomal Instability (Chromosome Stability) 01/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2022
1	Hypoxia (Hypoxemia) 11/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019
1	Adenocarcinoma 11/2017
1	Metrorrhagia (Spotting) 08/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 05/2017
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 11/2006
1	Hepatocellular Carcinoma (Hepatoma) 11/2006

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 02/2024 - 03/2011
6	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 02/2017
4	AntigensIBA 01/2023 - 01/2017
3	RNA (Ribonucleic Acid)IBA 12/2023 - 11/2016
3	Biomarkers (Surrogate Marker)IBA 02/2023 - 11/2017
3	AntibodiesIBA 01/2023 - 01/2017
3	Transcription Factors (Transcription Factor)IBA 01/2022 - 11/2010
2	Eosine Yellowish-(YS) (Eosin)IBA 02/2023 - 01/2022
2	Hematoxylin (Haematoxylon)IBA 02/2023 - 01/2022
2	Nucleic AcidsIBA 01/2023 - 10/2022
2	Immunoconjugates (Immunoconjugate)IBA 01/2023 - 01/2022
2	silicon phthalocyanineIBA 12/2022 - 01/2022
2	Immune Checkpoint InhibitorsIBA 01/2022 - 02/2017
2	Formaldehyde (Formol)FDA Link 01/2020 - 02/2017
2	beta CateninIBA 11/2007 - 11/2006
1	StreptavidinIBA 02/2024
1	Biotin (Vitamin H)FDA Link 02/2024
1	Lysophosphatidic Acid ReceptorsIBA 12/2023
1	DefensinsIBA 12/2023
1	Imiquimod (Aldara)FDA LinkGeneric 12/2023
1	InterleukinsIBA 12/2023
1	Proline (L-Proline)FDA Link 12/2023
1	InterferonsIBA 11/2023
1	Immunologic Factors (Immunomodulators)IBA 11/2023
1	Nucleotide AptamersIBA 11/2023
1	osteoblast cadherinIBA 02/2023
1	Therapeutic UsesIBA 01/2023
1	Immunoglobulins (Immunoglobulin)IBA 01/2023
1	EpitopesIBA 01/2023
1	Cys-ZHER2-342 affibodyIBA 12/2022
1	Aspartate-tRNA LigaseIBA 10/2022
1	Interferon-gamma (Interferon, gamma)IBA 10/2022
1	Cadherins (E-Cadherin)IBA 10/2022
1	AcidsIBA 01/2022
1	NucleotidesIBA 01/2022
1	human ERBB2 proteinIBA 01/2022
1	iminobiotinIBA 01/2022
1	Forkhead Box Protein M1IBA 01/2022
1	ApelinIBA 11/2021
1	RibonucleoproteinsIBA 10/2020
1	AutoantigensIBA 10/2020
1	Cell-Free Nucleic AcidsIBA 01/2020
1	MDS1 and EVI1 Complex Locus ProteinIBA 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	GlypicansIBA 11/2017
1	pyruvate dehydrogenase kinase 4IBA 05/2017
1	Valosin Containing ProteinIBA 04/2017
1	Chalcone (Benzalacetophenone)IBA 04/2017
1	xanthohumolIBA 04/2017
1	ParaffinIBA 02/2017
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2017
1	GlycosaminoglycansIBA 01/2017
1	LigandsIBA 11/2016
1	Oncogene Proteins (Oncogene Protein)IBA 03/2011
1	Tamoxifen FDA LinkGeneric 03/2009
1	Nonsense Codon (Nonsense Mutation)IBA 11/2006

Therapy/Procedure

6	Therapeutics 02/2024 - 11/2016
3	Immunotherapy 10/2020 - 01/2017
1	Intravesical Administration 11/2023
1	Investigational Therapies (Experimental Therapy) 03/2013